Key facts
- Ayumo’s last known valuation is $3.9M (Apr 2025).
- It has raised $680K; the latest was Seed Round ($680K) in Apr 2025.
- Notable investors include Japan External Trade Organization, Mayo Clinic Platform, Osaka University Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ayumo
- ·The full record, as it builds
Funding rounds
No funding rounds for Ayumo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ayumo
Developer of an AI-based healthcare platform designed to provide well-being services to users. The company's platform uses medical knowledge and AI technology to display possible diseases and support doctors' diagnoses, proposes a new flow of examinations by recording video, promotes digital transformation in the medical field, and detects locomotive syndrome objectively and quantitatively, and recommends and proposes appropriate measures for early recovery, enabling users to get well-being consultations and improve their health conditions.
- Sector
- Healthcare
- HQ
- Osaka, Japan
- Founded
- 2023
- Website
- ayumo.ai/
- Ownership
- Privately Held (backing)
Ayumo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ayumo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ayumo in its N-PORT filings yet. We sweep new filings monthly.